Menu

Advanced Tech, Crossover Investors Drive Biopharma IPO Surge

Wall Street Journal Pro

"After 15 US venture-backed life-sciences initial public offerings roared out of the gate in the third quarter, another crop looks poised to close out the year on a high note. The pace is set to continue this week with stock market debuts by PhaseBio Pharmaceuticals, LogicBio Therapeutics and SI-BONE. And just last week in its offering, liquid biopsy startup Guardant Health was valued at about $1.59 billion."

Read the article (subscription required)

Related Contacts
Div Gupta  Partner New York
Related Practices & Industries

Capital Markets  Public Companies  Life Sciences